interferon-gamma 1b

DRUG4 trials

Sponsors

InterMune

Conditions

Idiopathic Pulmonary FibrosisLung DiseasePulmonary Fibrosis

Phase 2

A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)

CompletedNCT00047658

InterMuneIdiopathic Pulmonary Fibrosis

Start: 2001-11-30End: 2003-05-31Updated: 2007-11-06

An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF)

CompletedNCT00052052

InterMuneLung Disease, Pulmonary Fibrosis

Start: 2002-09-30End: 2004-09-30Updated: 2007-11-06

Phase 3

A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)

CompletedNCT00047645

InterMuneIdiopathic Pulmonary Fibrosis

Start: 2000-04-30End: 2002-12-31Updated: 2007-11-02

A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving Prednisone

TerminatedNCT00052039

InterMuneLung Disease, Pulmonary Fibrosis

Start: 2002-04-30End: 2002-06-30Updated: 2007-11-06

Related Papers

A formula for predicting emphysema extent in combined idiopathic pulmonary fibrosis and emphysema.

2024-01-182 citations

The Single Breath Diffusing Capacity for Carbon Monoxide in Patients with Idiopathic Pulmonary Fibrosis: 6 Month Variability and Its Role in Predicting Forced Vital Capacity Change

2021-05-01

Changes in Neutrophil–Lymphocyte or Platelet–Lymphocyte Ratios and Their Associations with Clinical Outcomes in Idiopathic Pulmonary Fibrosis

Journal of Clinical Medicine2021-04-0132 citations

Effect of Emphysema Extent on Serial Lung Function in Patients with Idiopathic Pulmonary Fibrosis.

2017-11-0164 citations

Analysis of baseline characteristics by emphysema extent in patients with idiopathic pulmonary fibrosis (IPF)

2017-09-01